Coeptis Therapeutics Inc.
COEPDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819663
Coeptis Therapeutics Inc. was delisted in 2022; its insiders filed their last Form 4 on Nov 18, 2021; no institution reported holding it in 13F filings for Q3 2022; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q3 2022
- 13F value
- $0
- Reported value at the end of Q3 2022
- Superinvestors holding
- 0
- At the end of Q3 2022
Superinvestors holding COEP, Q3 2022
No superinvestor reported holding COEP at the end of Q3 2022.
Latest insider trades
Open-market purchases and sales by Coeptis Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Mehalick DavidCEO and President | SSale | −1.20M | – | – | −40.0%1.80M after |
Top 10 13F holders, Q3 2022
The largest institutional positions in Coeptis Therapeutics Inc. at the end of Q3 2022; share changes are against Q2 2022.
No institution reported holding COEP in 13F filings for Q3 2022.